97 related articles for article (PubMed ID: 1159048)
1. Disposition of a new, nonsteroid, antiandrogen, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide (Flutamide), in men following a single oral 200 mg dose.
Katchen B; Buxbaum S
J Clin Endocrinol Metab; 1975 Aug; 41(2):373-9. PubMed ID: 1159048
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous penetration and metabolism of topical (14C)flutamide in men.
Katchen B; Dancik S; Millington G
J Invest Dermatol; 1976 Jun; 66(6):379-82. PubMed ID: 932487
[TBL] [Abstract][Full Text] [Related]
3. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of the anti-androgenic action of flutamide (alpha-alpha-alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide) in the rat.
Peets EA; Henson MF; Neri R
Endocrinology; 1974 Feb; 94(2):532-40. PubMed ID: 4810387
[No Abstract] [Full Text] [Related]
5. The effects of a nonsteroid antiandrogen, flutamide, on sebaceous gland activity.
Lutsky BN; Budak M; Koziol P; Monahan M; Neri RO
J Invest Dermatol; 1975 Jun; 64(6):412-7. PubMed ID: 1141714
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats.
Clark CR; Merry BJ; Nowell NW
J Reprod Fertil; 1981 Jan; 61(1):189-91. PubMed ID: 7452616
[TBL] [Abstract][Full Text] [Related]
7. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment.
Schulz M; Schmoldt A; Donn F; Becker H
Eur J Clin Pharmacol; 1988; 34(6):633-6. PubMed ID: 3169114
[TBL] [Abstract][Full Text] [Related]
10. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
[TBL] [Abstract][Full Text] [Related]
11. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
12. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
[TBL] [Abstract][Full Text] [Related]
13. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
15. Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
Goda R; Nagai D; Akiyama Y; Nishikawa K; Ikemoto I; Aizawa Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2006 May; 34(5):828-35. PubMed ID: 16507648
[TBL] [Abstract][Full Text] [Related]
16. Effects of a non-steroidal antiandrogen on sexual behavior and pituitary-gonadal function in the male rat.
Södersten P; Gray G; Damassa DA; Smith ER; Davidson JM
Endocrinology; 1975 Dec; 97(6):1468-75. PubMed ID: 1204574
[TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
18. Dominant lethal study of the antiandrogen alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide: a comparison of statistical methods.
Beall JR
Toxicol Appl Pharmacol; 1974 May; 28(2):303-12. PubMed ID: 4851425
[No Abstract] [Full Text] [Related]
19. [Participation of the hypothalamus in the pituitary and testicular responses to administration of the antiandrogen 4-nitro-3-trifluoro-methylisobutyranilide].
Reznikov AG; Volkova NN
Biull Eksp Biol Med; 1979 Nov; 88(11):601-3. PubMed ID: 120207
[TBL] [Abstract][Full Text] [Related]
20. Physiological disposition and metabolism of timolol in man and laboratory animals.
Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
